Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 7;87(19):13023-13033.
doi: 10.1021/acs.joc.2c01561. Epub 2022 Sep 12.

A Bifurcated Multicomponent Synthesis Approach to Polycyclic Quinazolinones

Ruixue Xu  1 , Zefeng Wang  1 , Qiang Zheng  1 , Pravin Patil  1 , Alexander Dömling  1
Affiliations

A Bifurcated Multicomponent Synthesis Approach to Polycyclic Quinazolinones

Ruixue Xu et al. J Org Chem. .

Abstract

The rapid synthesis of diverse substituted polycyclic quinazolinones was achieved by two orthogonal Ugi four-component reaction (Ugi-4CR)-based protocols: the first two-step approach via an ammonia-Ugi-4CR followed by palladium-catalyzed annulation; in the second approach, cyanamide was used unprecedently as an amine component in Ugi-4CR followed by an AIBN/tributyltin hydride-induced radical reaction. Like no other method, MCR and cyclization could efficiently construct many biologically interesting compounds with tailored properties in very few steps.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Scheme 1
Scheme 1. Representatives and Synthesis of Polycyclic Quinazolinones
Scheme 2
Scheme 2. Substrate Scope in the [Pd]-Catalyzed Synthesis of Polycyclic Quinazolinones–
Acid, isocyanide, aldehyde, and ammonia components are depicted with red, green, blue, and pink color, respectively. Ugi reaction was carried out using 6 (1 mmol), 7 (1 mmol), 8 (1 mmol), and 9c (1 mmol) in TFE (1 M) for 12 h at r.t. [Pd]-catalyzed reaction conditions: 10–34a (0.2 mmol), Pd(OAc)2 (5 mol %), dppf (10 mol %), K2CO3 (1 mmol), 1,4 dioxane (2 mL), reflux, overnight. Yield refers to purified products.
Scheme 3
Scheme 3. Scale-up Synthesis
Scheme 4
Scheme 4. Synthesis of luotonin Derivatives
Scheme 5
Scheme 5. Various Isocyanides in the Synthesis of Polycyclic Quinazolinones via Radical Cyclization–
Acid, aldehyde, isocyanide, and cyanamide components are depicted with red, blue, green, and pink color, respectively. Ugi reaction was carried out using 36 (1 mmol), 37 (1 mmol), 8 (1 mmol), and 38 (1 mmol) in TFE (1 M) for 12 h at r.t. Radical cyclization conditions: 39–41a (0.15 mmol), tributyltin hydride (0.3 mmol), AIBN (0.15 mmol), benzene (7 mL), reflux, overnight. Yield refers to purified products.
See this image and copyright information in PMC

References

    1. Hameed A.; Al-Rashida M.; Uroos M.; Ali S. A.; Arshia; Ishtiaq M.; Khan K. M. Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011–2016). Expert Opin. Ther. Pat. 2018, 28, 281–297. 10.1080/13543776.2018.1432596. - DOI - PubMed
    2. Auti P. S.; George G.; Paul A. T. Recent advances in the pharmacological diversification of quinazoline/ quinazolinone hybrids. RSC Adv. 2020, 10, 41353–41392. 10.1039/D0RA06642G. - DOI - PMC - PubMed
    3. Biological activity of quinazolinones; Radwan A. A., Alanazi F. K. Eds.; Books on Demand: London, 2020.
    1. Shakhidoyatov K. M.; Elmuradov B. Z. Tricyclic quinazoline alkaloids: isolation, synthesis, chemical modification, and biological activity. Chem. Nat. Compd. 2014, 50, 781–800. 10.1007/s10600-014-1086-6. - DOI
    2. Cagir A.; Jones S. H.; Gao R.; Eisenhauer B. M.; Hecht S. M. Luotonin A. A naturally occurring human DNA topoisomerase I poison. J. Am. Chem. Soc. 2003, 125, 13628–13629. 10.1021/ja0368857. - DOI - PubMed
    3. Joshi B. K.; Gloer J. B.; Wicklow D. T.; Dowd P. F. Sclerotigenin: a new antiinsectan benzodiazepine from the sclerotia of Penicillium sclerotigenum. J. Nat. Prod. 1999, 62, 650–652. 10.1021/np980511n. - DOI - PubMed
    4. Tian K. M.; Li J. J.; Xu S. W. Rutaecarpine: a promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu). Pharmacol. Res. 2019, 141, 541–550. 10.1016/j.phrs.2018.12.019. - DOI - PubMed
    1. Dömling A. Recent developments in isocyanide based multicomponent reactions in applied chemistry. Chem. Rev. 2006, 106, 17–89. 10.1021/cr0505728. - DOI - PubMed
    2. Dömling A.; Ugi I. Multicomponent reactions with isocyanides. Angew. Chem., Int. Ed. 2000, 39, 3168–3210. 10.1002/1521-3773(20000915)39:18<3168::AID-ANIE3168>3.0.CO;2-U. - DOI - PubMed
    1. Dömling A.; Wang W.; Wang K. Chemistry and biology of multicomponent reactions. Chem. Rev. 2012, 112, 3083–3135. 10.1021/cr100233r. - DOI - PMC - PubMed
    2. Younus H. A.; Al-Rashida M.; Hameed A.; Uroos M.; Salar U.; Rana S.; Khan K. M. Multicomponent reactions (MCR) in medicinal chemistry: a patent review (2010-2020). Expert Opin. Ther. Pat. 2021, 31, 267–289. 10.1080/13543776.2021.1858797. - DOI - PubMed
    3. Rotstein B. H.; Zaretsky S.; Rai V.; Yudin A. K. Small heterocycles in multicomponent reactions. Chem. Rev. 2014, 114, 8323–8359. 10.1021/cr400615v. - DOI - PubMed
    1. Wang C.; Lai Z.; Xie H.; Cui S. Triazenyl Alkynes as Versatile Building Blocks in Multicomponent Reactions: Diastereoselective Synthesis of β-Amino Amides. Angew. Chem., Int. Ed. 2021, 60, 5147–5151. 10.1002/anie.202014686. - DOI - PubMed

Publication types